Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
KIA EV9 AND TELLURIDE NAMED 2025 KELLEY BLUE BOOK BEST BUY AWARD WINNERS
09:00am, Monday, 10'th Feb 2025
Kia EV9 named "Best 3-Row Electric Vehicle" for the second consecutive year Kia Telluride recognized as the "Best Midsize SUV" for sixth straight year – setting a KBB record for the most wins in thi
The documentary, from Bad Robot, Glen Powell's Barnstorm Productions, Zipper Bros Films, IMAX Entertainment and Dolphin Entertainment, follows a year in the life of the Blue Angels from training throu
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced new and updated data from LYFGENIA™ (lovotobegligene autotemcel, or lovo-cel) gene therapy for patients with sic
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced updated data from patients with beta-thalassemia who require regular blood transfusions treated with betibeglogene
NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, "Engine" or "we"), which owns approximately 7.1% of the issued and outstanding common shares of Dye & Durham Limited (TSX: D
bluebird bio Announces 1-for-20 Reverse Stock Split
04:05pm, Wednesday, 04'th Dec 2024
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it will proceed with a 1-for-20 reverse stock split (“Reverse Sto
bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model
08:47am, Wednesday, 04'th Dec 2024
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has reached an agreement with the Center for Medicare and Medicaid Innovation to offer an
THE DISTINCT COBALT BLUE OF SARATOGA® SPRING WATER NOW HAS AN OFFICIAL PANTONE® COLOR: SARATOGA® SIGNATURE BLUE, COLOR 286 C
09:00am, Monday, 02'nd Dec 2024
Official designation by the global authority on color to anchor creative programming at Design Miami, and partnerships with acclaimed chef Curtis Stone and Television Personality Kathy Hilton TAMPA, F
FDA investigates risk of blood cancers from bluebird bio's gene therapy
11:45am, Wednesday, 27'th Nov 2024
The U.S. Food and Drug Administration said on Wednesday it is investigating reports of blood cancers in patients who were treated with bluebird bio's gene therapy Skysona.
Wynnefield Group also Releases Detailed Investor Presentation that Has Been Posted to www.RebuildTPCSCredibility.com Urges ALL TechPrecision Stockholders to Take Immediate Action by Voting Each and Ev
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Blue Owl C
My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys
08:10am, Wednesday, 20'th Nov 2024
Investment activity in October focused on Business Development Companies, with $1,300 added to the market. Adjusted dividend income in October of $789, up 25% Y/Y and up 11% sequentially. Main picks i
JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
02:05pm, Friday, 15'th Nov 2024
On Thursday, Bluebird Bio Inc. BLUE reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a year ago, beating the consensus loss of 36 cents.
bluebird bio downgraded by Bank of America, shares tumble
12:38pm, Friday, 15'th Nov 2024
bluebird bio Inc (NASDAQ:BLUE) shares shed more than 11% on Friday after the Massachusetts-based biotech company developing gene therapies for severe genetic diseases was downgraded by Bank of Ameri
bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript
10:06am, Thursday, 14'th Nov 2024
bluebird bio, Inc. (NASDAQ:BLUE ) Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ET Company Participants Courtney O'Leary - Director, Investor Relations Andrew Obenshain - Chief Executive
